Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)

Ahmet M. Ulusan(Hackensack University Medical Center), Roderick H. Dashwood(Oregon State University)
Cancer Prevention Research
December 4, 2020
10.1158/1940-6207.capr-20-0262
Cited by 18

Related Papers

Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and β-catenin expression in the rat
|Carcinogenesis|2008|34
Alternative splicing of BAZ1A in colorectal cancer disrupts the DNA damage response and increases chemosensitization
|Cell Death and Disease|2024|5